Veritable’s Cabaletta Bio CABA Stock Holding History

Veritable’s Portfolio CABA Stock Details CABA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-37,245	Closed	-$481K	–	114
2023 Q2	$481K	Hold	37,245	–	–	0.01%	557
2023 Q1	$308K	Hold	37,245	–	–	0.01%	679
2022 Q4	$345K	Hold	37,245	–	–	0.01%	623
2022 Q3	$24K	Hold	37,245	–	–	﹤0.01%	787
2022 Q2	$39K	Hold	37,245	–	–	﹤0.01%	879
2022 Q1	$76K	Buy	37,245 +26,745	+255%	+$69.9K	﹤0.01%	893
2021 Q4	$40K	Hold	10,500	–	–	﹤0.01%	903
2021 Q3	$128K	Hold	10,500	–	–	﹤0.01%	861
2021 Q2	$90K	Hold	10,500	–	–	﹤0.01%	854
2021 Q1	$117K	Hold	10,500	–	–	﹤0.01%	818
2020 Q4	$131K	Hold	10,500	–	–	﹤0.01%	770
2020 Q3	$114K	Hold	10,500	–	–	﹤0.01%	719
2020 Q2	$117K	Buy	+10,500	New	+$80.4K	﹤0.01%	740

Other funds holding CABA

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Adage Capital Partners

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Cormorant Asset Management Boston, Massachusetts $1.98B AUM 737.95% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return